The AHA, Association of American Medical Colleges, America’s Essential Hospitals, and Federation of American Hospitals today urged the Centers for Medicare & Medicaid Services to share additional information with hospitals and the public about how accurately its overall hospital quality star ratings portray hospital performance and work with hospitals to validate the methodology, or continue to withhold publication of the ratings. “Since the sole purpose for creating the star ratings was to provide accurate information to the public to guide their decision-making about where to get their care, hospitals and patients alike must have meaningful information on whether the assessment is fair and accurate,” the organizations wrote. “…In fact, the minimal data available to us do not offer substantive proof that the methodology works as it was intended, and raise many more questions and concerns about the methodology than they answer.” Further, an analysis by an independent expert “gave us strong reason to believe that the assumptions on which the current model is based are flawed in a number of ways,” the organizations said. For more on the issue, see today’s AHA STAT blog post by AHA President and CEO Rick Pollack.

Headline
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…